Engerix-B

Engerix-B is a vaccine designed to prevent hepatitis B infection. It contains hepatitis B surface antigen (rDNA) and alum adjuvant, offering protection against the virus. This vaccine is suitable for individuals at risk of exposure to hepatitis B.

Engerix-B is primarily used to prevent hepatitis B, a viral infection that can cause serious liver damage. It is often recommended for individuals who are at higher risk of exposure, such as healthcare workers, travelers to regions with high hepatitis B prevalence, and those with certain medical conditions. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus.

Common effects of Engerix-B may include mild soreness, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or fatigue. These effects are usually temporary and resolve on their own. Severe reactions are rare but should be reported to a healthcare professional.

Engerix-B should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or medications. Pregnant or breastfeeding individuals should consult a healthcare professional before receiving the vaccine.

Engerix-B may interact with certain medications or other vaccines. It is important to inform the healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol consumption should be avoided before and after receiving the vaccine, as it may affect the immune response.